[1]
Z. Apalla, “Cutaneous Adverse Events of Immune Checkpoint Inhibitors: A Literature Review”, Dermatol Pract Concept, vol. 11, no. 1, p. e2021155, Jan. 2021, doi: 10.5826/dpc.1101a155.